Keywords: entremed, starts, ph, i/ii, trial, endostatin, enrolled

EntreMed starts Ph I/II trial of endostatin

Article | 13 July 2001

Print This

EntreMed has enrolled the first patients into its Phase I/II trial ofits angiogenesis inhibitor, recombinant human endostatin, which is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in